Using Artificial Intelligence and machine learning
to identify harmful chemicals
Accumulated Cost at Approval
$987 million – $2.5 billion
Limited Regulatory Requirements
Required Tests Cover Few Biological Targets
Biological Differences Between Humans and Animal Models
Reduce the need for animal testing
Future-proof chemical ingredient portfolios
Ultra-high throughput for new and existing chemicals
100 AI-MODELS OF HUMAN TOXICITY
Sensorygen can screen 10M+ purchasable compounds.
ToxAI™ screens compounds in the following areas:
Food & Beverage
EPA Registered Compounds
Flavors & Fragrances
FDA Registered Compounds
Cosmetics & Personal Care
Supplements, therapeutics, & drugs
ToxAI™ Cloud Software Suite
AI estimates for clinical success and approval based on comprehensive tox and property profiles.
Supply a target chemical, retrieve several alternatives with maximal physicochemical or perceptual similarity, and ranked by most promising estimated tox profiles.
Access an extensive probability landscape for any chemicals’ long-term impact on the human body, anticipate and protect against future risks.
AI-models Simulates Standard* Safety Tests:
- *Acute Oral Toxicity
- *Acute Dermal Toxicity
- *Dermal Sensitization
- *Acute Inhalation
- *Dermal Irritation
- *Eye Irritation
- Blood Brain Barrier Permeability
Automatically build custom models using Sernsorygen’s AI engine, simply supply the data. The pipeline offers full automation, with flexibility to intervene or choose models and operations, accommodating users with different levels of experience and needs.
Explore “smart” chemical databases, curated naturals (~700,000) and synthetics (>10 million). The AI-guided search platform provides users with 100s of property and tox estimates for filtering.
Discovery is the engine that drives our product pipeline
For more information or to partner with Sensorygen, please contact our team.